Equities

Nova Eye Medical Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nova Eye Medical Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.165
  • Today's Change0.00 / 0.00%
  • Shares traded51.07k
  • 1 Year change+26.92%
  • Beta1.6793
Data delayed at least 20 minutes, as of Feb 13 2026 01:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nova Eye Medical Limited is an Australia-based medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. The Company operates through two segments: AlphaRET, and Glaucoma surgical devices. The Company’s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is a treatment to delay progression to late-stage age-related macular degeneration (AMD) for patients who have the disease in its intermediate stage. 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.

  • Revenue in AUD (TTM)29.27m
  • Net income in AUD-9.06m
  • Incorporated1970
  • Employees130.00
  • Location
    Nova Eye Medical Ltd3-4 Second AvenueADELAIDE 5095AustraliaAUS
  • Phone+61 88104-5200
  • Fax+61 88104-5231
  • Websitehttps://nova-eye.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CONNEQT Health Ltd3.55m-18.19m26.94m26.00--38.21--7.58-0.0507-0.05070.010.00120.32350.438910.72---165.59-99.31-618.20-249.1671.9784.29-511.88-208.530.6557-2.370.8527---68.20-5.10-168.93---33.92--
Genetic Signatures Ltd21.36m-20.10m31.80m----0.6348--1.49-0.0899-0.08990.09420.22050.35051.176.04---32.98-16.72-35.71-18.3156.7255.89-94.10-38.679.49-143.040.0156--49.698.55-12.55---17.43--
Atomo Diagnostics Ltd3.79m-4.97m33.22m----4.34--8.76-0.0077-0.00770.00590.00940.36721.072.83---48.13-30.62-57.46-33.1050.6240.54-131.08-113.092.27--0.0259---10.53-6.7227.41---55.73--
Curvebeam AI Ltd12.10m-16.84m36.79m50.00--0.8507--3.04-0.0453-0.04530.03230.09050.19460.634310.20---27.10---31.21--44.89---139.24--1.22-80.930.3366--85.33--27.09------
ImpediMed Ltd12.72m-23.24m37.72m77.00--1.83--2.96-0.0115-0.01150.00630.01010.28712.165.51165,246.80-52.43-42.33-59.33-48.4986.2585.16-182.62-195.144.71-112.780.4142--23.3117.25-17.42---14.47--
BCAL Diagnostics Ltd2.65m-7.24m44.17m----7.06--16.67-0.0201-0.02010.00740.0170.239--0.9573---65.31-57.98-87.92-72.00-----273.21-249.54----0.2766---13.0143.11-13.14--190.46--
Vitasora Health Ltd3.71m-10.11m46.45m2.00--2.69--12.54-0.0071-0.00710.00270.00930.30130.01064.17---82.17-118.94-115.44-176.5499.1978.72-272.73-533.630.6694--0.0039--256.7710.92-41.74------
HeraMED Ltd322.93k-4.53m46.77m----63.84--144.84-0.0059-0.00590.00040.00070.13810.37941.57---193.87-129.03-316.53-221.1458.7058.67-1,404.05-2,178.902.33--0.468---39.9011.7418.96------
Nova Eye Medical Ltd29.27m-9.06m48.42m130.00--2.55--1.65-0.0373-0.03730.11830.06681.042.927.08---32.13-21.38-39.78-24.9764.5478.66-30.95-46.441.85-121.420.1372--24.8117.95-3.06---14.69--
Cleanspace Holdings Ltd19.76m-478.27k50.16m----2.61113.572.54-0.0062-0.00620.25380.24480.73721.954.94---1.78-6.87-2.07-8.2974.7674.57-2.42-10.494.46--0.1914--25.72-6.9984.71---23.72--
Micro-X Ltd13.05m-13.90m60.99m----7.43--4.67-0.023-0.0230.02140.01130.53280.56653.51---56.71-41.13-95.63-53.7279.0568.51-106.45-104.841.13-30.400.464---14.2511.56-42.29---46.10--
Singular Health Group Ltd702.02k-6.26m69.07m----5.07--98.39-0.0258-0.02660.0030.04340.0848--7.39---75.64-120.64-86.15-162.51-----892.01-824.18---599.390.00---25.7740.56-117.55---1.59--
Data as of Feb 13 2026. Currency figures normalised to Nova Eye Medical Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

14.08%Per cent of shares held by top holders
HolderShares% Held
Australian Ethical Investments Ltd. (Investment Management)as of 07 Feb 202540.11m14.08%
Data from 02 Feb 2026 - 02 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.